Vizai

Viz.ai is an applied AI healthcare company pioneering the use of deep learning technology in medicine. We are exploring how advances in computer science can work to identify patients and notify the right doctor directly; enable faster communication, selection, transportation, and intervention. Our work to date has focussed on stroke and other neurological disease. Our flagship product Viz LVO Stroke Platform is FDA cleared under a De Novo classification and CE Marked. Viz.ai has received funding from Danhua Capital (DHVC) and ex-Google Chairman Eric Schmidt's Innovation Endeavors, as well as AME Cloud Ventures and Susa Ventures. We are joined by an advisory board with world-class expertise in neurovascular care, medical imaging, workflow design and healthcare policy.